The Punjab government is taking a big step to improve the quality of medicines across the province. It has announced plans to set up a state-of-the-art bioequivalence laboratory at a cost of Rs2 billion. Punjab Chief Minister Maryam Nawaz has already received an initial briefing on this important project.
The new lab will test medicines according to international standards. It will check the quality, effectiveness, and performance of generic drugs through scientific methods. This facility is expected to reduce the number of substandard medicines in the market and give patients safer treatment options.
Currently, many local pharmaceutical companies send their medicines abroad for testing, which costs a lot of foreign money and takes time. The new lab will allow testing inside Pakistan, saving valuable foreign exchange and lowering costs for the industry. It will also help improve the overall standard of locally made medicines.
Officials believe the laboratory will support Pakistan’s pharmaceutical exports by meeting global requirements. It will encourage more research, innovation, and new investments in the health sector. The project is part of broader efforts to strengthen drug quality control and make Punjab’s pharma industry more competitive in world markets.
This initiative shows the Punjab government’s focus on public health and local industry growth. By building modern testing facilities, the province aims to protect citizens from poor-quality drugs and boost confidence in made-in-Pakistan medicines. Once completed, the lab is likely to become a key center for quality assurance in the country.